Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Flat illustration of a drug compound and a symbol for cardiometabolic disease

Oct 16, 2026

AI in drug discovery & development: News watch, October 2026

Recent advancements in the biopharma sector highlight significant partnerships and funding initiatives aimed at leveraging AI for drug discovery and development, underscoring the industry's growing reliance on technology to address complex health challenges.AstraZeneca has formed a substantial partnership with insitro, committing $40 million upfront and potentially up to $1.5 billion in total, to utilize insitro's AI-driven platform for researching drug targets related to cardiometabolic disease
Press release cover image

Oct 16, 2026

Press release

Battelle Extends Longstanding CDC Partnership with New Public Health Data and Mission Support Awards

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle today announced two significant awards from the Centers for Disease Control and Prevention (CDC), reinforcing the organization's longstanding partnership in advancing public health through data, analytics, science, and mission support services.Battelle was awarded a five-year, $12.3 million contract to provide information systems and technical data support for CDC's National Environmental Public Health (NEPH) Tracking Network, a critical resource that in
Press release cover image

Oct 15, 2026

Press release

Reveleer Names Digital Health Innovator Dr. Jean-Luc Neptune Chief Medical Officer

Dr. Neptune will lead clinical strategy for Reveleer across risk adjustment, quality, and member management programs serving 12 million covered livesGLENDALE, Calif., Oct. 15, 2026 /PRNewswire/ -- Reveleer, an AI-enabled value-based care technology company for health plans and provider organizations, today announced the appointment of Jean-Luc ("JL") Neptune, MD, MBA, as Chief Medical Officer. Dr. Neptune will help set clinical direction for Reveleer products and bring a seasoned clinical voice
A test tube with a colorful liquid in a dimly lit lab

Oct 15, 2026

Bringing GPT-Rosalind to academic research labs

The introduction of the Rosalind Academic Plan aims to enhance access to GPT-Rosalind, a specialized AI model tailored for life sciences research, for eligible academic labs.This initiative allows academic researchers to leverage advanced AI tools, which can significantly aid in various scientific inquiries, from drug development to genomics. Eligible labs can receive up to 30 free seats for a year, contingent on trusted-access approval. This support is part of OpenAI's broader mission to accele
Press release cover image

Oct 15, 2026

Press release

Tucuvi joins the Microsoft Pegasus Program to scale clinically governed AI Care Management across health systems

Tucuvi brings a differentiated clinical approach to conversational AI within the Microsoft Pegasus Program, extending voice AI beyond administrative interactions into clinically governed care management.BOSTON, Oct. 15, 2026 /PRNewswire/ -- Tucuvi, an AI care management company, today announced it is joining the Microsoft for Startups Pegasus Program, which connects companies to Microsoft's enterprise customer ecosystem and go-to-market channels.For Tucuvi, the selection comes at a pivotal momen
Minimalist illustration of a microexon and brain tissue

Oct 15, 2026

Newly Identified Microexons Offer Clues to Autism Spectrum Disorder’s Genetic Roots

Recent research highlights the significance of newly identified microexons in understanding the genetic underpinnings of autism spectrum disorder (ASD).Collaborative efforts from institutions such as the University of Toronto and the Sloan Kettering Institute have unveiled hundreds of microexons potentially linked to ASD and other neurological disorders. Published in *Nature*, the study utilized a computational tool named MicroExonator to sift through vast RNA sequencing datasets, leading to the
Press release cover image

Oct 15, 2026

Press release

Colait Launches Neuroscience Data Collection Initiative, Advancing the Case for Clinical Opinion as a Core Layer of Real-World Evidence

Boston, October 15, 2026 — Colait today announced thelaunch of a structured clinical opinion data collection initiative inneuroscience, marking the company's first large-scale therapeutic area studyand a significant expansion of what will become the first nationally representativequalitative clinical opinion dataset across therapy areas.The announcement comes as industry leaders gather in Bostonthis week to examine the future of scientific innovation and the growingimperative to rebuild trust in
Press release cover image

Oct 15, 2026

Press release

In HelloNation, Cosmetic Dentistry Expert Dr. Michael Cohen Examines Smile Design Before Treatment

The article explains how digital planning supports dental aesthetics, improves patient experience, and leads to more predictable treatment outcomes.BOCA RATON, Fla., Oct. 15, 2026 /PRNewswire/ -- What should patients expect before beginning cosmetic dentistry treatment? The answer is provided in a HelloNation article that highlights insights from Cosmetic Dentistry Expert Dr. Michael Cohen of Big Boca Smiles in Boca Raton.Continue Reading Speed SpeedTh
A tissue sample on a lab bench with a microscope in the background.

Oct 15, 2026

Illumina Combines Multiomics Informatics Applications in New BioInsight Platform

Illumina has introduced the BioInsight platform, a comprehensive software environment designed to enhance the analysis of multiomics datasets, ahead of the 2026 ASHG meeting.The BioInsight platform aims to streamline access to Illumina’s suite of analysis tools, artificial intelligence applications, and curated data resources, allowing scientists to extract actionable insights more efficiently. This initiative stems from Illumina's recognition of a need for improved analytical capabilities to ma
Press release cover image

Oct 15, 2026

Press release

XtalPi Nominates Its First siRNA Preclinical Candidate for IgA Nephropathy Nine Months After Program Initiation

Preclinical data demonstrate subnanomolar silencing potency, achieving an IC50 tens of times lower than the corresponding values for two clinical-stage reference molecules targeting the same target.In non-human primates, a single dose maintained robust target-protein suppression for months, demonstrating a durable pharmacodynamic effect and supporting the potential for extended dosing intervals.Using Kodexia™ platform, XtalPi applied generative AI to identify a previously unexplored active targe
Press release cover image

Oct 15, 2026

Press release

ELEPHAS PUBLISHES PEER-REVIEWED DATA IN CELL REPORTS MEDICINE DEMONSTRATING elive™ PLATFORM'S IMMUNOTHERAPY RESPONSE MEASUREMENT

Study Demonstrates 93% Accuracy in Predicting Clinical Benefit and Highlights the Platform's Potential to Enhance Clinical Decision Making MADISON, Wis., Oct. 15, 2026 /PRNewswire/ -- Elephas Biosciences Corporation, a private company that has developed an innovative live tissue platform for immunotherapy response prediction, announced today the publication of peer-reviewed data in Cell Reports Medicine evaluating the predictive performance of its elive platform. The study evaluated live tumor f
Press release cover image

Oct 15, 2026

Press release

Neumarker and Cortica Enter Strategic Partnership to Advance Precision Autism Care

Strategic Collaboration Focused on Precision Autism CarePartnership Brings Together Neumarker’s AI Platform and Cortica’s Clinical Expertise MOUNTAIN VIEW, Calif. and SAN DIEGO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Neumarker, Inc. (“Neumarker”), a private techbio company harnessing the power of artificial intelligence (AI) for precision CNS medicine, and Cortica, Inc. (“Cortica”), a leading provider of advanced neurological therapies for children with autism and other developmental differences, a